## Presented at the Consensus Conference on the Because it has been documented that only a minority of patients Classification of Ductal Carcinoma In Situ, Phildevelop invasive cancer after excision of DCIS, some physicians have adelphia, Pennsylvania, April 25-28, 1997. been treating selected pat
Consensus conference on the classification of ductal carcinoma in Situ
โ Scribed by Robert J. Rosser
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 89 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
OR: odds ratio; CI: confidence interval. a Estimates are from multiple logistic regression equations, including terms for center, age, gender, education, total alcohol intake, and family history of colorectal carcinoma. b Reference category. c The sum does not add up to the total because some values are missing.
๐ SIMILAR VOLUMES
Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr
Ductal carcinoma in situ (DCIS) was a relatively uncommon disease process when we relied on palpation to detect breast lesions. With the advent of more widespread mammography screenings, the surgeon is faced with a welcome opportunity to prevent cancer by dealing with a precursor lesion. Discovering
MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human adenocarcinomas, this protein is up-regulated and/or underglycosylated, and its expression changes from apical to the entire cell membrane. It is thought